Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Lost 33% in January

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) were falling in January as the biotech stock was affected by the broad sell-off in growth stocks, and as investors seemed to fear that the company's tailwinds from its COVID vaccine may have peaked. Company-specific news last month was mixed, though there were some positive steps, including full authorization from the FDA for its COVID vaccine.

According to data from S&P Global Market Intelligence, the stock finished the month down 33%. The shares fell steadily through most of January.